Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,110.00 GBX | +0.04% |
|
+0.27% | +5.73% |
Jun. 16 | CEO moves between industries | RE |
Jun. 13 | Reckitt Benckiser in Exclusive Talks with Advent for Essential Home Sale | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13.99B | 13.23B | 14.45B | 14.61B | 14.17B | |||||
Total Revenues | 13.99B | 13.23B | 14.45B | 14.61B | 14.17B | |||||
Cost of Goods Sold, Total | 5.56B | 5.54B | 6.09B | 5.85B | 5.57B | |||||
Gross Profit | 8.44B | 7.69B | 8.36B | 8.76B | 8.6B | |||||
Selling General & Admin Expenses, Total | 5B | 4.65B | 4.68B | 5.11B | 4.99B | |||||
R&D Expenses | 288M | 313M | 325M | 337M | 325M | |||||
Other Operating Expenses | -2M | -3M | -9M | -3M | -172M | |||||
Other Operating Expenses, Total | 5.29B | 4.96B | 5B | 5.44B | 5.15B | |||||
Operating Income | 3.14B | 2.73B | 3.36B | 3.32B | 3.45B | |||||
Interest Expense, Total | -276M | -244M | -233M | -295M | -393M | |||||
Interest And Investment Income | 61M | 29M | 29M | 41M | 53M | |||||
Net Interest Expenses | -215M | -215M | -204M | -254M | -340M | |||||
Income (Loss) On Equity Invest. | -1M | -3M | -2M | - | - | |||||
Currency Exchange Gains (Loss) | - | 764M | -37M | 15M | -13M | |||||
Other Non Operating Income (Expenses) | -71M | -4M | -7M | -35M | 14M | |||||
EBT, Excl. Unusual Items | 2.86B | 3.27B | 3.11B | 3.04B | 3.11B | |||||
Restructuring Charges | - | - | - | - | -167M | |||||
Merger & Related Restructuring Charges | - | -14M | - | - | - | |||||
Impairment of Goodwill | -985M | - | -167M | -810M | -696M | |||||
Gain (Loss) On Sale Of Investments | - | - | -19M | - | - | |||||
Gain (Loss) On Sale Of Assets | - | -3.52B | 142M | 166M | - | |||||
Asset Writedown | - | - | - | - | -143M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 1.87B | -260M | 3.07B | 2.4B | 2.1B | |||||
Income Tax Expense | 720M | -208M | 711M | 753M | 672M | |||||
Earnings From Continuing Operations | 1.15B | -52M | 2.36B | 1.65B | 1.43B | |||||
Earnings Of Discontinued Operations | 50M | 31M | -7M | 9M | -4M | |||||
Net Income to Company | 1.2B | -21M | 2.35B | 1.66B | 1.43B | |||||
Minority Interest | -16M | -11M | -19M | -14M | -2M | |||||
Net Income - (IS) | 1.19B | -32M | 2.33B | 1.64B | 1.43B | |||||
Net Income to Common Incl Extra Items | 1.19B | -32M | 2.33B | 1.64B | 1.43B | |||||
Net Income to Common Excl. Extra Items | 1.14B | -63M | 2.34B | 1.63B | 1.43B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.67 | -0.04 | 3.26 | 2.29 | 2.04 | |||||
Basic EPS - Continuing Operations | 1.6 | -0.09 | 3.27 | 2.28 | 2.04 | |||||
Basic Weighted Average Shares Outstanding | 711M | 714M | 715M | 717M | 700M | |||||
Net EPS - Diluted | 1.66 | -0.04 | 3.25 | 2.29 | 2.03 | |||||
Diluted EPS - Continuing Operations | 1.59 | -0.09 | 3.26 | 2.27 | 2.04 | |||||
Diluted Weighted Average Shares Outstanding | 714M | 714M | 717M | 718M | 702M | |||||
Normalized Basic EPS | 2.49 | 2.85 | 2.69 | 2.64 | 2.77 | |||||
Normalized Diluted EPS | 2.48 | 2.85 | 2.68 | 2.63 | 2.77 | |||||
Dividend Per Share | 1.75 | 1.75 | 1.83 | 1.92 | 2.02 | |||||
Payout Ratio | 104.55 | -3.89K | 53.61 | 81.5 | 96.84 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.48B | 3.02B | 3.65B | 3.61B | 3.75B | |||||
EBITA | 3.23B | 2.8B | 3.4B | 3.35B | 3.48B | |||||
EBIT | 3.14B | 2.73B | 3.36B | 3.32B | 3.45B | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 38.44 | 80 | 23.18 | 31.36 | 31.94 | |||||
Total Current Taxes | 695M | 764M | 743M | 805M | 700M | |||||
Total Deferred Taxes | 25M | -972M | -32M | -52M | -28M | |||||
Normalized Net Income | 1.77B | 2.03B | 1.93B | 1.89B | 1.94B | |||||
Interest on Long-Term Debt | 13M | 13M | 16M | 14M | 13M | |||||
Non-Cash Pension Expense | -5M | 3M | -6M | -6M | -6M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | - | - | - | 2.16B | |||||
Selling and Marketing Expenses | 3.61B | 3.46B | 3.44B | 3.7B | 3.54B | |||||
General and Administrative Expenses | 1.39B | 1.19B | 1.25B | 1.41B | 1.46B | |||||
Research And Development Expense From Footnotes | 288M | 313M | 325M | 337M | 325M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 15M | 30M | 78M | 102M | 85M | |||||
Total Stock-Based Compensation | 15M | 30M | 78M | 102M | 85M |
- Stock Market
- Equities
- RB. Stock
- Financials Reckitt Benckiser Group plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions